BioSpace News Archive

Business

Kodiak CMO Steps Down After Phase III Flops for Eye Therapy

After the company’s investigational eye therapy recently failed two late-stage studies, Kodiak Sciences’ Chief Medical Officer and Chief Development Officer Jason Ehrlich has resigned from his roles.

August 18, 2023
·
2 min read
·
Tristan Manalac
FDA

Regeneron’s Antibody Gets FDA Approval for Ultra-Rare Hereditary Disease

The regulator’s greenlight on Friday for Regeneron Pharmaceuticals’ monoclonal antibody Veopoz (pozelimab) makes it the first and only treatment indicated for children and adults with CHAPLE disease.

August 18, 2023
·
2 min read
·
Connor Lynch
Drug Development

Genethon’s Gene Therapy for Rare Liver Disease Shows Promising Early-Stage Results

In a European Phase I/II clinical trial, the experimental drug for treating Crigler-Najjar syndrome reduced bilirubin below toxic threshold in the liver with a single intravenous injection.

August 18, 2023
·
2 min read
·
Connor Lynch
Drug Development

Week in Review: Obesity Drug Race, Ipsen Therapy Finally Gets Approval and More

Boehringer Ingelheim will launch three Phase III studies for its obesity drug candidate; third time is a charm for Ipsen as it gets FDA approval; and Pfizer takes multiple myeloma battle to J&J.

August 18, 2023
·
2 min read
·
Greg Slabodkin
Drug Development

Pfizer, Moderna Target Emerging Variants with Updated COVID-19 Shots

The companies contend that their updated COVID-19 vaccines for the fall vaccination season can elicit strong immune responses against the virus’ currently dominant and emerging subvariants.

August 18, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Merck’s Welireg Clears Phase III Primary Endpoint in Renal Cell Carcinoma

The company is continuing its renal cell carcinoma push for its oral HIF-2α inhibitor Welireg with promising Phase III data showing significant progression-free survival improvements in patients.

August 18, 2023
·
2 min read
·
Tristan Manalac
Co-Diagnostics, Inc. to Present at 15th Next Generation Dx Summit in Washington, D.C.

Co-Diagnostics, Inc. announced today that it will be sponsoring, presenting and hosting a booth at the 15th Annual Next Generation Dx Summit, held virtually and in-person in Washington, D.C. on August 21-23, 2023.

August 18, 2023
·
1 min read
Business

Nexcella Announces Dr. Heather Landau, Memorial Sloan Kettering Cancer Center Amyloidosis Program Director, Joins Nexcella Scientific Advisory Board

Dr. Landau joins the Nexcella Scientific Advisory Board with decades of hematology/oncology clinical trial experience at Memorial Sloan Kettering Cancer Center.

August 18, 2023
·
5 min read
Clinical Trials Market Size Estimated to Hit USD 83,550 Million by 2032

The global clinical trials market size reached USD 48,680 million in 2022 and is estimated to hit around USD 83,550 million by 2032, expanding at a CAGR of 5.6% from 2023 to 2032, As per the study by Towards Healthcare.

August 18, 2023
·
10 min read
Bio NC

Dentsply Sirona to Participate in the Baird 2023 Global Healthcare Conference

DENTSPLY SIRONA Inc. announced that the Company will participate in the Baird 2023 Global Healthcare Conference.

August 18, 2023
·
1 min read